Fresenius looks for refi after Moody’s upgrade

medial technologies
By Silas Brown
08 Jun 2017

Fresenius Medical Care (FMC) — the dialysis specialist 30% owned by healthcare group Fresenius — is looking to refinance loan facilities, a month after Moody’s upgraded the firm to investment grade

Bank meetings will be held in June, in Frankfurt, London and New York. 

BBB-/Baa3/BBB- rated FMC is looking for five year loans to replace existing facilities, set to expire in October 2019. 

Introduced in 2014, when FMC was rated Ba1/BB+/BB+, the loan comprised two ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.